1. Home
  2. PGEN vs SGML Comparison

PGEN vs SGML Comparison

Compare PGEN & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.55

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Sigma Lithium Corporation

SGML

Sigma Lithium Corporation

HOLD

Current Price

$12.01

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
SGML
Founded
1998
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
PGEN
SGML
Price
$5.55
$12.01
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
$8.33
$18.75
AVG Volume (30 Days)
5.5M
2.4M
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$272.11
Revenue Next Year
$81.04
$36.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$4.25
52 Week High
$5.61
$24.48

Technical Indicators

Market Signals
Indicator
PGEN
SGML
Relative Strength Index (RSI) 74.63 34.41
Support Level $4.00 $10.98
Resistance Level N/A $16.87
Average True Range (ATR) 0.32 0.94
MACD 0.15 -0.15
Stochastic Oscillator 96.70 1.56

Price Performance

Historical Comparison
PGEN
SGML

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About SGML Sigma Lithium Corporation

Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.

Share on Social Networks: